PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.753
+0.102 (15.72%)
At close: Mar 6, 2026, 4:00 PM EST
0.755
+0.002 (0.21%)
After-hours: Mar 6, 2026, 7:41 PM EST
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.08 million as of March 6, 2026. Its market cap has decreased by -35.84% in one year.
Market Cap
8.08M
Enterprise Value
-12.52M
1-Year Change
-35.84%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.08M, a decrease of -52.45%. That is a compound annual growth rate of -5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.60M | 4.11% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 7.73M |
| Kiora Pharmaceuticals | 7.52M |
| Alzamend Neuro | 7.50M |
| Pulmatrix | 7.38M |
| Evogene | 7.34M |
| Alaunos Therapeutics | 7.32M |
| Quoin Pharmaceuticals | 7.12M |
| Moolec Science | 7.06M |